Bixiye
Agamree (vamorolone), Emflaza (deflazacort) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2025
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 551 - 560 ee natiijooyinka 3607
Bixiye
QP96R1-23 EXL Health (EXL) to Perform Inpatient Facility Claim Reviews
Taariikhda wax ku ool ah ee barnaamijka: Jun 26, 2024
Bixiye
QP51-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 15, 2024
Taariikhda wax ku ool ah ee barnaamijka: Jun 26, 2024
Bixiye
QP50-24 Training Webinars for New Medical Drug Vendor, MagellanRx Management
Taariikhda wax ku ool ah ee barnaamijka: Jun 26, 2024
Bixiye
QP52-24 Appeal Submissions Now Available in Availity Essentials: Create, Submit and Inquire for Minnesota Health Care Programs Post-Service Claim Appeals
Taariikhda wax ku ool ah ee barnaamijka: Jun 26, 2024
Bixiye
QP49-24 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective July 1, 2024
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2024
Bixiye
QP46-24 Provider Press: Q2 2024
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2024
Bixiye
QP80R1-21 BlueRide announces No-Load Program for Non-Emergency Medical Transportation (NEMT) in Greater Minnesota
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2024
Bixiye
QP48-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 1, 2024
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2024